Search
Search Results
##search.searchResults.foundPlural##
-
-
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4620PDF: 1786HTML: 1230 -
-
-
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1275PDF: 625HTML: 6918 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1418PDF: 486HTML: 18625Figure 1: 186Figure 2: 165Figure 3: 184Figure 4: 219Figure 5: 195 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
3018PDF: 1145HTML: 129 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3719PDF: 2600HTML: 1626 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1698PDF: 945HTML: 3194Figure 5: 175Figure 4: 174Figure 3: 209Figure 1: 189Figure 2: 188 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3354PDF: 1512HTML: 5966Fig1-Ag-Pil: 260Ag-Pil Fig.2: 259 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3860PDF: 1647HTML: 859Figures . Eliassian: 253 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1475PDF: 857HTML: 3137 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1920PDF: 878HTML: 1641 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2694PDF: 1674HTML: 2451Table1: 212 -
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
2285HTML: 653PDF: 1391 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3005PDF: 1410HTML: 3723Untitled: 217Untitled: 227Untitled: 200 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3353PDF: 1064HTML: 2404 -
-
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3705PDF: 1267HTML: 5091Incidence age-standardized rates for HL across the Mediterranean basin: 233 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3448PDF: 2042HTML: 7573 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2289PDF: 1011HTML: 1982 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1361PDF: 948HTML: 338 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
973PDF: 711Suppl. Files: 142HTML: 153 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1096PDF: 958Suppl. Files: 611HTML: 104 -
CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL
1379PDF: 549HTML: 296 -
NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION
1837PDF: 1021HTML: 1879Tables: 198 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1528PDF: 1372HTML: 114 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4361Suppl. Files: 1220PDF: 1130Html: 265 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
1105PDF: 584HTML: 7881 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2102PDF: 840HTML: 1226







